Esthesioneuroblastoma (olfactory neuroblastoma) with hemorrhage: an unusual presentation.

Prakash Sampath, Michael C Park, Dara Huang, Curtiland Deville, Selina Cortez, Prakash Chougule
Author Information
  1. Prakash Sampath: Department of Clinical Neurosciences Program in Neurosurgery, Division of Neuropathology, Brown Medical School, Rhode Island Hospital, Providence, Rhode Island. prakash_sampath@hotmail.com

Abstract

Esthesioneuroblastoma (olfactory neuroblastoma) is an uncommon neuroectodermal tumor. Its biological activity ranges from indolent growth to local recurrence and rapid widespread metastasis. Treatment options consist of surgical resection followed by radiation therapy for primary lesions and the addition of chemotherapy for advanced, recurrent, or metastatic lesions. Patients often present with nasal obstruction, rhinorrhea, recurrent epistaxis, hyposmia, or anosmia. However, we report the highly unusual case of a patient with an esthesioneuroblastoma who presented with atypical symptoms of headaches, sinus congestion, and fatigue before acutely losing consciousness. Imaging showed a large frontal skull-based tumor associated with intratumoral hemorrhage. The findings prompted an emergent combined anterior craniofacial resection with gross total resection of the tumor. Except for anosmia, the patient recovered almost completely. Postoperatively, she received adjuvant intensity-modulated radiation therapy and chemotherapy. This is the first reported case of an esthesioneuroblastoma presenting with hemorrhage and rapidly declining mental status, an acute neurological manifestation of which clinicians should be aware.

References

  1. Laryngoscope. 1999 Oct;109(10):1539-43 [PMID: 10522919]
  2. Laryngoscope. 1990 Oct;100(10 Pt 1):1052-8 [PMID: 2215035]
  3. Cancer. 1989 Jun 15;63(12):2426-8 [PMID: 2720589]
  4. Ann Otol Rhinol Laryngol. 1977 Nov-Dec;86(6 Pt 1):760-5 [PMID: 596773]
  5. J Am Med Assoc. 1955 Jan 22;157(4):318-21 [PMID: 13221415]
  6. J Neurooncol. 1995 Oct;26(1):35-43 [PMID: 8583243]
  7. Ear Nose Throat J. 1998 Nov;77(11):890-1 [PMID: 9846465]
  8. Lancet Oncol. 2001 Nov;2(11):683-90 [PMID: 11902539]
  9. Anticancer Res. 1997 Jul-Aug;17(4A):2683-706 [PMID: 9252701]
  10. Otolaryngol Head Neck Surg. 2004 May;130(5):567-74 [PMID: 15138422]
  11. Cancer. 1979 Sep;44(3):1087-94 [PMID: 383268]
  12. Head Neck. 2000 Sep;22(6):550-8 [PMID: 10941155]
  13. Neurosurg Clin N Am. 2000 Oct;11(4):693-701 [PMID: 11082179]
  14. Cancer. 1976 Mar;37(3):1571-6 [PMID: 1260676]
  15. Head Neck. 1995 Mar-Apr;17(2):114-8 [PMID: 7558807]
  16. Curr Opin Otolaryngol Head Neck Surg. 2003 Apr;11(2):112-8 [PMID: 14515089]
  17. Laryngoscope. 1992 Aug;102(8):843-9 [PMID: 1495347]
  18. Arch Otolaryngol Head Neck Surg. 2003 Nov;129(11):1186-92 [PMID: 14623748]

Word Cloud

Created with Highcharts 10.0.0tumorresectionEsthesioneuroblastomaolfactoryneuroblastomaradiationtherapylesionschemotherapyrecurrentanosmiaunusualcasepatientesthesioneuroblastomahemorrhageuncommonneuroectodermalbiologicalactivityrangesindolentgrowthlocalrecurrencerapidwidespreadmetastasisTreatmentoptionsconsistsurgicalfollowedprimaryadditionadvancedmetastaticPatientsoftenpresentnasalobstructionrhinorrheaepistaxishyposmiaHoweverreporthighlypresentedatypicalsymptomsheadachessinuscongestionfatigueacutelylosingconsciousnessImagingshowedlargefrontalskull-basedassociatedintratumoralfindingspromptedemergentcombinedanteriorcraniofacialgrosstotalExceptrecoveredalmostcompletelyPostoperativelyreceivedadjuvantintensity-modulatedfirstreportedpresentingrapidlydecliningmentalstatusacuteneurologicalmanifestationcliniciansawarehemorrhage:presentation

Similar Articles

Cited By